Discounted Cash Flow (DCF) Analysis Unlevered

Bruush Oral Care Inc. (BRSH)

$0.054

-0.00 (-4.93%)
All numbers are in Millions, Currency in USD
Stock DCF: -10,478.43 | 0.054 | overvalue

Operating Data

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 0.210.902.622.637.2519.9454.90151.10415.90
Revenue (%)
EBITDA -1.36-8.33-5.47-10.49-39.64-109.11-300.32-826.62-2,275.28
EBITDA (%)
EBIT -1.36-8.33-5.48-10.51-39.67-109.19-300.55-827.28-2,277.08
EBIT (%)
Depreciation --0.010.020.030.090.240.651.79
Depreciation (%)

Balance Sheet Data

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 0.180.690.020.093.058.3923.0963.56174.95
Total Cash (%)
Account Receivables 0.010.080.200.200.551.524.1911.5331.73
Account Receivables (%)
Inventories 0.601.180.830.248.3322.9463.13173.76478.28
Inventories (%)
Accounts Payable 0.260.242.300.914.9413.6137.45103.08283.74
Accounts Payable (%)
Capital Expenditure --0-0.01-0-0.02-0.05-0.14-0.38-1.04
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 0.054
Beta 0.000
Diluted Shares Outstanding 7.34
Cost of Debt
Tax Rate 63.74
After-tax Cost of Debt 1.81%
Risk-Free Rate
Market Risk Premium
Cost of Equity 4.285
Total Debt -
Total Equity 0.40
Total Capital 0.40
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 0.210.902.622.637.2519.9454.90151.10415.90
EBITDA -1.36-8.33-5.47-10.49-39.64-109.11-300.32-826.62-2,275.28
EBIT -1.36-8.33-5.48-10.51-39.67-109.19-300.55-827.28-2,277.08
Tax Rate 0.00%0.00%0.00%63.74%15.94%15.94%15.94%15.94%15.94%
EBIAT -1.36-8.33-5.48-3.81-33.35-91.79-252.66-695.45-1,914.21
Depreciation --0.010.020.030.090.240.651.79
Accounts Receivable --0.07-0.12-0-0.35-0.97-2.67-7.34-20.20
Inventories --0.580.350.59-8.09-14.60-40.19-110.63-304.52
Accounts Payable --0.022.06-1.394.038.6623.8465.63180.65
Capital Expenditure --0-0.01-0-0.02-0.05-0.14-0.38-1.04
UFCF -1.36-9-3.19-4.60-37.75-98.67-271.58-747.51-2,057.52
WACC
PV UFCF -37.75-94.61-249.69-659.01-1,739.30
SUM PV UFCF -2,665.98

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 4.29
Free cash flow (t + 1) -2,098.68
Terminal Value -91,645.20
Present Value of Terminal Value -74,284.19

Intrinsic Value

Enterprise Value -76,950.17
Net Debt -0.07
Equity Value -76,950.09
Shares Outstanding 7.34
Equity Value Per Share -10,478.43